Form 4: J.H. Whitney Equity Partners VII, LLC Reduces Stake in Aveanna Healthcare Holdings, Inc.
SEC Form 4
J.H. Whitney Equity Partners VII, LLC reports the sale of Aveanna Healthcare Holdings, Inc. shares through a pre-arranged Rule 10b5-1 trading plan.
Summary
- J.H. Whitney Equity Partners VII, LLC, a 10% owner of Aveanna Healthcare Holdings, Inc. (AVAH), filed a Form 4 disclosing changes in beneficial ownership.
- The transactions involved the sale of common stock on April 1, 2025, and April 2, 2025, under a Rule 10b5-1 trading plan.
- The sales were executed at a weighted average price of $5.63 per share.
- A total of 3,610 shares were sold on April 1, 2025, and 8,166 shares were sold on April 2, 2025, by J.H. Whitney VII, L.P.
- PSA Healthcare Investment Holding LLC sold 1,803 shares on April 1, 2025, and 4,080 shares on April 2, 2025.
- PSA Iliad Holdings LLC sold 167 shares on April 1, 2025, and 378 shares on April 2, 2025.
- Following these transactions, J.H. Whitney VII, L.P. beneficially owns 31,376,094 shares, PSA Healthcare Investment Holding LLC owns 15,675,833 shares, and PSA Iliad Holdings LLC owns 1,451,220 shares.
- The sales were conducted under a pre-existing 10b5-1 trading plan adopted on December 13, 2024.
Sentiment
Score: 5
Explanation: The sentiment is neutral as the filing simply reports transactions under a pre-existing trading plan. There is no indication of positive or negative outlook for the company.
Industry Context
This filing indicates activity by a major shareholder, J.H. Whitney Equity Partners VII, LLC, in Aveanna Healthcare Holdings, Inc. The sales are being conducted under a pre-arranged trading plan, which is a common practice for insiders to diversify their holdings while avoiding accusations of trading on non-public information. It is important to monitor further filings to understand the full extent of the shareholder's intentions.
Comparison to Industry Standards
- It is difficult to compare this transaction to industry standards without knowing the specific investment strategy of J.H. Whitney Equity Partners VII, LLC.
- However, sales under 10b5-1 plans are common among large shareholders in publicly traded companies.
- Comparable transactions would involve similar filings by major shareholders in other healthcare companies, such as Option Care Health (OPCH) or LHC Group (LHCG), disclosing sales under pre-arranged trading plans.
Stakeholder Impact
- The sale of shares by a major shareholder could create short-term selling pressure on the stock.
- However, since the sales are conducted under a pre-arranged plan, the impact may be limited.
Key Dates
| Date | Description |
|---|---|
| 2024-12-13 | Date of adoption of Rule 10b5-1 trading plan by J.H. Whitney VII, L.P., PSA Healthcare Investment Holding LLC, JHW Iliad Holdings LLC, and PSA Iliad Holdings LLC. |
| 2025-04-01 | Date of first reported transaction: sale of common stock at $5.63. |
| 2025-04-02 | Date of second reported transaction: sale of common stock at $5.63. |
| 2025-04-03 | Date of signature of the Form 4 filing. |
Keywords
Form 4, Aveanna Healthcare Holdings, AVAH, J.H. Whitney Equity Partners, Stock Sale, Beneficial Ownership, Rule 10b5-1
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.